Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Chimerix Inc (CMRX)

Chimerix Inc (CMRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 78,821
  • Shares Outstanding, K 89,630
  • Annual Sales, $ 320 K
  • Annual Income, $ -82,100 K
  • 60-Month Beta 1.12
  • Price/Sales 236.55
  • Price/Cash Flow N/A
  • Price/Book 0.49
Trade CMRX with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.95
  • Most Recent Earnings $-0.23 on 08/13/24
  • Next Earnings Date 11/07/24
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Options Overview Details

View History
  • Implied Volatility 0.00% ( -100.06%)
  • Historical Volatility 77.06%
  • IV Percentile 0%
  • IV Rank 0.00%
  • IV High 354.84% on 02/23/24
  • IV Low 0.00% on 09/18/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 7
  • Volume Avg (30-Day) 208
  • Put/Call OI Ratio 0.29
  • Today's Open Interest 12,631
  • Open Int (30-Day) 11,998

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/24
See More
  • Average Estimate -0.24
  • Number of Estimates 5
  • High Estimate -0.23
  • Low Estimate -0.28
  • Prior Year -0.27
  • Growth Rate Est. (year over year) +11.11%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.8500 +1.18%
on 09/06/24
1.1900 -27.73%
on 08/19/24
-0.1600 (-15.69%)
since 08/16/24
3-Month
0.7500 +14.67%
on 08/13/24
1.1900 -27.73%
on 08/19/24
-0.0120 (-1.38%)
since 06/18/24
52-Week
0.7500 +14.67%
on 08/13/24
1.3000 -33.85%
on 03/08/24
-0.1700 (-16.50%)
since 09/18/23

Most Recent Stories

More News
Chimerix: Q2 Earnings Snapshot

Chimerix: Q2 Earnings Snapshot

CMRX : 0.8600 (-2.21%)
Rapid Advancements of Innovative Antiviral – COVID-19 Drugs Generating Major Growth in Global Antiviral Drugs Market

EQNX::TICKER_START (NYSE:NNVC),(NASDAQ:BCRX),(NASDAQ:VERU),(NASDAQ:CMRX),(NASDAQ:SIGA) EQNX::TICKER_END

BCRX : 7.96 (+0.51%)
NNVC : 1.6600 (+4.40%)
VERU : 0.7700 (-1.67%)
CMRX : 0.8600 (-2.21%)
SIGA : 7.97 (+1.14%)
Rapid Advancements of Innovative Antiviral – COVID-19 Drugs Generating Major Growth in Global Antiviral Drugs Market

NNVC : 1.6600 (+4.40%)
VERU : 0.7700 (-1.67%)
CMRX : 0.8600 (-2.21%)
SIGA : 7.97 (+1.14%)
Chimerix: Q1 Earnings Snapshot

Chimerix: Q1 Earnings Snapshot

CMRX : 0.8600 (-2.21%)
Chimerix: Q4 Earnings Snapshot

Chimerix: Q4 Earnings Snapshot

CMRX : 0.8600 (-2.21%)
Chimerix: Q3 Earnings Snapshot

Chimerix: Q3 Earnings Snapshot

CMRX : 0.8600 (-2.21%)
Chimerix: Q2 Earnings Snapshot

Chimerix: Q2 Earnings Snapshot

CMRX : 0.8600 (-2.21%)
Chimerix: Q1 Earnings Snapshot

Chimerix: Q1 Earnings Snapshot

CMRX : 0.8600 (-2.21%)
Chimerix: Q4 Earnings Snapshot

Chimerix: Q4 Earnings Snapshot

CMRX : 0.8600 (-2.21%)
Rubric Capital Management Sends Letter to Chimerix Board of Directors

Rubric Capital Management LP (“Rubric”), an investment adviser whose managed funds and accounts collectively own approximately 8.5% of the common stock of Chimerix, Inc. (“Chimerix” or the “Company”)...

CMRX : 0.8600 (-2.21%)

Business Summary

Chimerix is a biopharmaceutical company which develop medicines for lives of patients facing deadly diseases. The Company's most advanced clinical-stage development program ONC201, is in development for H3 K27M-mutant glioma. Chimerix is based in DURHAM, N.C.

See More

Key Turning Points

3rd Resistance Point 0.9217
2nd Resistance Point 0.9093
1st Resistance Point 0.8847
Last Price 0.8600
1st Support Level 0.8477
2nd Support Level 0.8353
3rd Support Level 0.8107

See More

52-Week High 1.3000
Fibonacci 61.8% 1.0899
Fibonacci 50% 1.0250
Fibonacci 38.2% 0.9601
Last Price 0.8600
52-Week Low 0.7500

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar